리나디엠메트서방정5/1000밀리그램(리나글립틴|메트포르민)
Recall Summary Linagliptin/Metformin Extended-Release 5/1000mg tablets are being recalled in South Korea due to potential excess levels of the impurity N-nitroso-meglumine. The recall, classified as Class II, affects products with specific barcodes (8806427075506 and 8806427075513) distributed by Dong Wha Pharmaceuticals and currently in circulation.
- Recalling firm
- 동화약품(주)
- Product
- 리나디엠메트서방정5/1000밀리그램(리나글립틴|메트포르민) (Barcode: 8806427075506, 8806427075513)
- Reason
- 불순물(N-nitroso-meglumine)초과검출우려에따른사전예방적조치로시중유통품에대한영업자회수
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-07-02
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/ab859bfe-850e-44a4-a1b5-d510db906cf8